101 related articles for article (PubMed ID: 1949846)
21. Transfusion support in liver transplantation.
Triulzi DJ
Curr Hematol Rep; 2004 Nov; 3(6):444-9. PubMed ID: 15496279
[TBL] [Abstract][Full Text] [Related]
22. [Therapy using blood components. Prerequisites, indications and clinical use].
Glück D; Kubanek B; Ahnefeld FW
Infusionsther Klin Ernahr; 1986 Oct; 13(5):240-9. PubMed ID: 3804436
[TBL] [Abstract][Full Text] [Related]
23. Blood component replacement therapy.
Coffland FI; Sheleton DM
Crit Care Nurs Clin North Am; 1993 Sep; 5(3):543-56. PubMed ID: 8217049
[TBL] [Abstract][Full Text] [Related]
24. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes.
Corash L
Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276
[TBL] [Abstract][Full Text] [Related]
25. A simple automatized audit system for following and managing practices of platelet and plasma transfusions in a neonatal intensive care unit.
Petäjä J; Andersson S; Syrjälä M
Transfus Med; 2004 Aug; 14(4):281-8. PubMed ID: 15285724
[TBL] [Abstract][Full Text] [Related]
26. [Current technologies for blood loss prevention during abdominal hysterectomy].
Fedorova TA; Ragimov AA; Bogomazova IV; Rogachevskiĭ OV; Dzhabrailova DA
Anesteziol Reanimatol; 2007; (6):48-51. PubMed ID: 18326259
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy of 2 different leukocyte filters for erythrocyte concentrates].
Barth A; Passerini M; Oppliger R; Spycher M; Nydegger U
Schweiz Med Wochenschr; 1993 Jun; 123(22):1160-4. PubMed ID: 8322051
[TBL] [Abstract][Full Text] [Related]
28. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience.
Wall DA; Carter SL; Kernan NA; Kapoor N; Kamani NR; Brochstein JA; Frangoul H; Goyal RK; Horan JT; Pietryga D; Wagner JE; Kurtzberg J;
Biol Blood Marrow Transplant; 2005 Aug; 11(8):637-46. PubMed ID: 16041314
[TBL] [Abstract][Full Text] [Related]
29. TRALI risk reduction: donor and component management strategies.
Eder AF; Benjamin RJ
J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
[TBL] [Abstract][Full Text] [Related]
30. Platelet alloantigens and transfusion.
Wautier JL
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):171-8. PubMed ID: 8337118
[TBL] [Abstract][Full Text] [Related]
31. [Leukocyte depletion of blood products. Indications and technical implementation].
Böck M; Heim MU
Fortschr Med; 1995 Mar; 113(8):102-4. PubMed ID: 7759031
[TBL] [Abstract][Full Text] [Related]
32. Leucodepletion leads to component-like storage stability of whole blood--suggesting its homologous use?
Picker SM; Stürner SS; Oustianskaja L; Gathof BS
Vox Sang; 2004 Oct; 87(3):173-81. PubMed ID: 15569069
[TBL] [Abstract][Full Text] [Related]
33. [Transfusion related graft versus host disease. Indications for irradiated blood components].
Muñiz-Díaz E; Martínez Valverde C; Sierra J; Madoz P
Sangre (Barc); 1999 Dec; 44(6):483-8. PubMed ID: 10822764
[No Abstract] [Full Text] [Related]
34. [Thrombocyte substitution in hematologic patients].
Wiesneth M
Beitr Infusionsther; 1993; 31():86-91. PubMed ID: 7693270
[TBL] [Abstract][Full Text] [Related]
35. [Results in the use of blood components separated by cytophoresis in leukemia treated with cytostatics (our 1st experiences with flowing-effect centrifuge)].
Bosković S; Haracić M
Bilt Hematol Transfuz; 1976; 4(1-2):97-104. PubMed ID: 942368
[TBL] [Abstract][Full Text] [Related]
36. [HLA and transfusion].
Wittmann G; Zimmermann R; Eckstein R
Infusionsther Transfusionsmed; 1994 Jun; 21(3):207-12. PubMed ID: 7919910
[TBL] [Abstract][Full Text] [Related]
37. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805
[TBL] [Abstract][Full Text] [Related]
38. Pathogen reduction of blood components.
Solheim BG
Transfus Apher Sci; 2008 Aug; 39(1):75-82. PubMed ID: 18602343
[TBL] [Abstract][Full Text] [Related]
39. [The current potentials for optimal whole-blood transfusion and component therapy with blood products--erythrocytes in obstetrics and gynecology--the indications, means and methods].
Nikolov A; Kovachev I; Gŭrcheva L; Dimitrov A
Akush Ginekol (Sofiia); 1998; 37(4):46-9. PubMed ID: 10360055
[No Abstract] [Full Text] [Related]
40. Leukocyte reduction of cellular blood components. Effectiveness, benefits, quality control, and costs.
Lane TA
Arch Pathol Lab Med; 1994 Apr; 118(4):392-404. PubMed ID: 8166589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
